Salusin-β accelerates inflammatory responses in vascular endothelial cells via NF-κB signaling in LDL receptor-deficient mice in vivo and HUVECs in vitro

American Journal of Physiology. Heart and Circulatory Physiology
Takayuki KoyaAkira Miyazaki

Abstract

The bioactive peptide salusin-β is highly expressed in human atheromas; additionally, infusion of antiserum against salusin-β suppresses the development of atherosclerosis in atherogenic mice. This study examined the roles of salusin-β in vascular inflammation during atherogenesis. Infusion of antiserum against salusin-β attenuated the induction of VCAM-1, monocyte chemoattractant protein (MCP)-1, and IL-1β and as well as nuclear translocation of NF-κB in aortic endothelial cells (ECs) of LDL receptor-deficient mice, which led to the prevention of monocyte adhesion to aortic ECs. In vitro experiments indicated that salusin-β directly enhances the expression levels of proinflammatory molecules, including VCAM-1, MCP-1, IL-1β, and NADPH oxidase 2, as well as THP-1 monocyte adhesion to cultured human umbilical vein ECs (HUVECs). Both salusin-β-induced VCAM-1 induction and monocyte/HUVEC adhesion were suppressed by pharmacological inhibitors of NF-κB, e.g., Bay 11-7682 and curcumin. Furthermore, the VCAM-1 induction was significantly prevented by the phosphatidylinositol 3-kinase (PI3K) inhibitor LY-294002, whereas it was accelerated by the ERK inhibitor, U-0126. Treatment of HUVECs with salusin-β, but not with salusin-α, accelerat...Continue Reading

References

Oct 20, 1995·The Journal of Biological Chemistry·S Singh, B B Aggarwal
May 23, 1998·Arteriosclerosis, Thrombosis, and Vascular Biology·Y NakashimaR Ross
Jan 14, 1999·The New England Journal of Medicine·R Ross
Oct 30, 1999·Basic Research in Cardiology·M Toborek, S Kaiser
Aug 2, 2000·Proceedings of the National Academy of Sciences of the United States of America·L HajraM I Cybulsky
May 26, 2001·The Journal of Clinical Investigation·M I CybulskyD S Milstone
Aug 12, 2003·Nature Medicine·Masayoshi ShichiriYukio Hirata
Feb 26, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Menno P J de WintherMarten H Hofker
Jun 3, 2006·Arteriosclerosis, Thrombosis, and Vascular Biology·Oscar López-FrancoCarmen Gómez-Guerrero
Jan 20, 2007·Arteriosclerosis, Thrombosis, and Vascular Biology·Ulf LandmesserHelmut Drexler
May 24, 2008·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Takuya WatanabeAkira Miyazaki
Oct 25, 2008·Arteriosclerosis, Thrombosis, and Vascular Biology·Hideto YamadaYoshihiro Ogawa
Dec 3, 2008·Cell Metabolism·Ralph GareusManolis Pasparakis
Aug 8, 2009·Regulatory Peptides·Kengo SatoMasayoshi Shichiri
Oct 20, 2009·American Journal of Physiology. Heart and Circulatory Physiology·Courtney P JudkinsGrant R Drummond
Nov 17, 2009·Arteriosclerosis, Thrombosis, and Vascular Biology·Bernard Lassègue, Kathy K Griendling
Jan 5, 2011·Peptides·Noriko SuzukiYukio Hirata
Aug 13, 2011·Circulation Research·Jong-Gil ParkGoo Taeg Oh
Sep 20, 2011·Journal of the American Society of Hypertension : JASH·Takuya WatanabeMasayoshi Shichiri
Mar 30, 2012·Circulation Research·Katrin SchröderRalf P Brandes

❮ Previous
Next ❯

Citations

Nov 20, 2013·International Journal of Hypertension·Kengo SatoTakuya Watanabe
Jul 20, 2013·Expert Opinion on Therapeutic Targets·Mayumi MasumuraMitsuaki Isobe
Dec 19, 2012·Biotechnic & Histochemistry : Official Publication of the Biological Stain Commission·I Sahin, S Aydin
May 27, 2016·Genetic Testing and Molecular Biomarkers·Tao WangHong-Yun Cao
Feb 13, 2016·Scientific Reports·Noriko Suzuki-KemuriyamaMasayoshi Shichiri
Mar 16, 2017·Biotechnic & Histochemistry : Official Publication of the Biological Stain Commission·M CakirF Ozyalin
Mar 24, 2017·Cell Death & Disease·Ming-Xia ZhaoGuo-Qing Zhu
Mar 10, 2017·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Shuai JiangYang Yang
Feb 15, 2020·The Journal of International Medical Research·Yuxue WangXiaolu Mao
Sep 17, 2017·Journal of Basic and Clinical Physiology and Pharmacology·Ayhan TanyeliTuğba Bal
Mar 3, 2015·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·Jun LiuLi Kang
Dec 11, 2017·Biochemistry. Biokhimii︠a︡·Maryam EsfahaniRezvan Najafi
Jan 22, 2020·Heart and Vessels·Koichiro ShibataTakuya Watanabe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Adhesion Molecules in AS

Cell adhesion molecules expressed on the vascular endothelium and circulating leukocytes in response to inflammatory stimuli are implicated in atherosclerosis. Here is the latest research.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.